- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06404970
A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings
A Partnered Evaluation to Improve Identification and Management of Functional Impairment and Frailty for Older Veterans in VA Primary Care
Study Overview
Status
Conditions
Detailed Description
Background: Maintaining functional status, or the ability to perform daily activities such as bathing, dressing, and preparing meals, is central to older adults' quality of life, health, and ability to remain independent. Identifying functional impairments - defined as having difficulty or needing help performing these activities - is essential for clinicians to provide optimal care to older adults, and on a population level, understanding function can help anticipate service needs. Yet uptake of standardized measurement of functional status into routine patient care has been slow and inconsistent due to the burden posed by current tools. The purpose of the proposed QUERI Partnered Evaluation Initiative is to implement and evaluate the Patient-Aligned Care Team (PACT) Functional Status Screening Initiative (hereafter "PACT Function Initiative"), a patient-centered, low-burden intervention to improve measurement of functional status in VA primary care settings nationally.
Significance/Impact: Implementing routine measurement of functional status in primary care has the potential to improve identification and management of functional impairment for older Veterans. Improved management includes increasing access to services and supports, reducing potentially preventable acute care utilization, and allowing Veterans to live in the least restrictive setting for as long as possible. The proposed QUERI Partnered Evaluation Initiative is directly aligned with national VA strategic priorities including VA's Aging in Place and Aging and Frail Veterans initiatives (Objective 2.2) and developing Data as a Strategic Asset (Objective 4.2) to inform evidence-based decisions.
Innovation: The PACT Function Initiative is novel because it addresses prior barriers to functional status measurement. It incorporates Veteran and caregiver preferences while minimizing burden for primary care teams and maximizing clinical effectiveness. Implementing this intervention will provide functional status data that is directly actionable for patient care while creating a repository of data to inform VA strategic planning.
Specific Aims: (1) Measure clinician- and organization-level reach, adoption, implementation, and sustainment of the PACT Function Initiative; (2) Compare the effectiveness of a standard versus enhanced implementation bundle to improve adoption; (3) Measure patient-level clinical effectiveness of the intervention; and (4) To inform future GEC initiatives, test the effectiveness of EHR-based frailty screening for identifying Veterans at risk for functional impairment. The investigators hypothesize that implementing the PACT Function Initiative will result in increased identification and improved management of functional impairment among older Veterans while providing key data to inform VHA strategic planning related to long-term services and supports.
Methodology: In partnership with GEC and Primary Care, the investigators will implement and evaluate the PACT Function Initiative using a hybrid type 2 implementation-effectiveness cluster-randomized adaptive trial design with three phases: pre-implementation, implementation, and sustainment. The investigators will use the Practical, Robust Implementation and Sustainability Model (PRISM) to guide implementation and evaluation. During pre-implementation, the investigators will engage stakeholders and develop local adaptations to maximize intervention-setting fit. During implementation, the investigators will launch a standard bundle of implementation strategies (champions, system-level audit and feedback), identify sites with low uptake, and randomize those sites to receive continued standard vs. enhanced strategies (technical assistance, clinician-level audit and feedback).
Next Steps/Implementation: Establishing routine, standardized measurement of functional status and frailty among older Veterans will provide data to inform the delivery of proactive interventions to prevent and delay the development of functional impairment and improve quality of life, health, and independence.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rebecca T Brown, MD MPH
- Phone Number: (215) 823-5800
- Email: rebecca.brown@va.gov
Study Contact Backup
- Name: Jason Prigge, BS MS
- Phone Number: 3883 (215) 823-5800
- Email: Jason.Prigge@va.gov
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104-4551
- Recruiting
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
-
Contact:
- Tonia C Reynolds-Hendricks, BA MA
- Phone Number: 206080 215-823-5800
- Email: Tonia.Reynolds-Hendricks@va.gov
-
Contact:
- Johann Ochoa, MS
- Phone Number: (215) 823-5821
- Email: johann.ochoa2@va.gov
-
Principal Investigator:
- Rebecca T. Brown, MD MPH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Veteran
- >60 years old
- Seen in Veterans Health Administration primary care after implementation begins
Exclusion Criteria:
- Non-Veteran
- <60 years old
- Not seen in Veterans Health Administration primary care
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Functional status screening initiative plus standard bundle of implementation strategies
During an initial 3 month run-in period, the investigators will implement the intervention at all sites using the standard implementation strategy bundle (implementation champions, system-level audit and feedback).
After run-in, the investigators will identify sites with inadequate Reach, defined as <80% of eligible Veterans receiving screening and/or assessment.
Sites with >80% Reach at the end of run-in will receive standard implementation for all phases of implementation.
For sites with <80% Reach, the investigators will randomize 1:1 by medical center to 3 additional months of a standard vs. enhanced implementation bundle.
The enhanced implementation bundle will include technical assistance plus clinician-level audit and feedback.
After 3 months' implementation, the investigators will then perform 3 months of crossover allocation.
After crossover allocation, both arms will receive 3 months of standard implementation.
|
Intervention to improve identification and management of functional impairment among older Veterans in VA primary care settings.
Intervention includes 5 components: (1) routine, standardized functional status measurement; (2) nursing screening followed by follow-up primary care provider assessment; (3) electronic tools and templates to facilitate screening, assessment, and documentation; (4) interprofessional educational session; (5) tailored reports on functional status
Other Names:
Standard strategies include champions plus system-level audit and feedback
|
|
Experimental: Functional status screening initiative plus enhanced bundle of implementation strategies
During an initial 3 month run-in period, the investigators will implement the intervention at all sites using the standard implementation strategy bundle (implementation champions, system-level audit and feedback).
After run-in, the investigators will identify sites with inadequate Reach, defined as <80% of eligible Veterans receiving screening and/or assessment.
Sites with >80% Reach at the end of run-in will receive standard implementation for all phases of implementation.
For sites with <80% Reach, the investigators will randomize 1:1 by medical center to 3 additional months of a standard vs. enhanced implementation bundle.
The enhanced implementation bundle will include technical assistance plus clinician-level audit and feedback.
After 3 months' implementation, the investigators will then perform 3 months of crossover allocation.
After crossover allocation, both arms will receive 3 months of standard implementation.
|
Intervention to improve identification and management of functional impairment among older Veterans in VA primary care settings.
Intervention includes 5 components: (1) routine, standardized functional status measurement; (2) nursing screening followed by follow-up primary care provider assessment; (3) electronic tools and templates to facilitate screening, assessment, and documentation; (4) interprofessional educational session; (5) tailored reports on functional status
Other Names:
Enhanced strategies include technical assistance plus clinician-level audit and feedback
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in reach
Time Frame: 9 months, 12 months, 15 months, 18 months, 24 months
|
Reach is defined as the proportion of eligible Veterans who receive LVN screening and PCP assessment at each center.
The investigators will identify eligible Veterans (i.e., 60 years old, seen in primary care after implementation begins) and use Health Factors to identify completed screening, defined as an LVN completing the electronic tool, and assessment, defined as a PCP reviewing screening results and either (a) documenting via checkbox that further referral is not needed or (b) placing a referral to address impairments.
|
9 months, 12 months, 15 months, 18 months, 24 months
|
|
Change in clinical effectiveness
Time Frame: 0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
The primary outcome is proportion of Veterans with impairments who receive appropriate referrals.
Appropriate referrals will be defined as the PCP reviewing the LVN screening results and either (1) documenting via checkbox that further referral is not needed or (2) placing a referral to address identified impairments.
|
0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
|
Change in association of electronic health record frailty indices with functional status
Time Frame: 0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
Frailty will be measured using the validated VA Frailty Index (VA-FI), calculated using the cumulative deficit method.
The VA-FI includes up to 31 age-related health deficits based on VA EHR diagnostic and procedure codes.
Categories include non-frail (0-0.1),
pre-frail (0.11-0.2), and frail (>0.2).
Functional status will be measured from Health Factors.
In sensitivity analyses, the investigators will examine other EHR frailty indices (e.g., JEN Index100)
|
0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recipient experience
Time Frame: Through study completion, from 0 to 24 months
|
Recipient experience will be assessed using interviews for Veterans and periodic reflections and interviews for clinicians and will be used to inform adaptations to intervention components and implementation strategies.
To operationalize processes within PRISM's Adoption, Implementation, and Maintenance domains, the investigators will use Normalization Process Theory (NPT) to guide qualitative data collection.
|
Through study completion, from 0 to 24 months
|
|
Change in adoption
Time Frame: 0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
Adoption is defined as (1) the proportion of LVNsat each medical center who regularly complete screening; and (2) the proportion of PCPs at each medical center who regularly complete assessment.
Adequate adoption for each clinician-type is defined as 80%.
|
0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
|
Change in adoption in clinician notes
Time Frame: 0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
The investigators will review a subset of charts at the 6 sampled centers to examine if clinician notes for the visit when screening was completed have content related to functional status and type of content.
|
0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
|
Change in fidelity
Time Frame: 0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
Fidelity to implementation strategies will be measured using Managerial Champion attendance at VISN-level monthly meetings (standard strategy) or technical assistance calls (enhanced strategy).
Fidelity to intervention core components will be measured at the 6-site subsample to determine if core components were implemented as intended, accounting for adaptations and modifications that were consistent vs. inconsistent with intent.
|
0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
|
Change in Maintenance/sustainability
Time Frame: 24 months
|
Maintenance/Sustainability will be measured as continued LVN screening and PCP assessment.
The investigators will define adequate maintenance as 80% at 6 months after beginning Sustainment (i.e., at 24 months overall).
|
24 months
|
|
Change in clinician capacity for implementation and sustainment
Time Frame: 9 months, 12 months, 15 months, 18 months, 24 months
|
To assess clinician capacity for implementation and sustainment, the investigators will use 3 validated survey measures: the Clinical Sustainability Assessment Tool (CSAT), Normalization MeAsurement Development (NoMAD) items, and Primary Care Team Dynamics (PC-TD) survey.
CSAT assesses 7 domains: engaged leadership; engaged stakeholders; organizational readiness; workflow integration; implementation and training; monitoring and evaluation; and outcomes and effectiveness (35 items, Likert scale; higher scores indicate greater capacity for sustainability).
NoMAD uses NPT constructs to identify patterns across individual factors: for example, the intervention makes sense to staff (coherence) but is failing due to low engagement (cognitive participation; 23 items, Likert scale, higher scores reflect higher normalization).
The PC-TD subscales measure shared understanding and communication (11 items, Likert scale, higher scores reflect more optimal team dynamics).
|
9 months, 12 months, 15 months, 18 months, 24 months
|
|
Change in facility-free days
Time Frame: 0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
Facility-free days measures the number of days a Veteran is alive and outside a hospital or SNF, calculated from GECDAC residential history files (RHF).
|
0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
|
Change in number of emergency department visits
Time Frame: 0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
Measured using GECDAC Core Files.
|
0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
|
Change in number of hospitalizations
Time Frame: 0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
Measured using GECDAC Core Files.
|
0 months, 9 months, 12 months, 15 months, 18 months, 24 months
|
|
Change in functional status
Time Frame: 9 months, 12 months, 15 months, 18 months, 24 months
|
Scored using screener for difficulty/need for help with each of 6 ADLs/7 IADLs.
No difficulty scored as 0, difficulty as 1, need for help as 2. Score ranges from 0-26 with higher scores indicating more severe functional impairment.
|
9 months, 12 months, 15 months, 18 months, 24 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Rebecca T. Brown, MD MPH, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
- Principal Investigator: Francesca M Nicosia, PhD MA, San Francisco VA Medical Center, San Francisco, CA
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEX 24-001
- PEC 23-072 (Other Grant/Funding Number: VA Quality Enhancement Research Initiative)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
McMaster UniversityRecruitingFrailty | Frailty Syndrome | Frail Older Adults | Frailty in AgingCanada
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Universidad Francisco de VitoriaActive, not recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric HealthSpain
-
University of IcelandLandspitali University HospitalRecruitingFrailty Syndrome | Elective Surgery | Frailty in Adult SurgeryIceland
-
Ji Yan Biomedical Co., Ltd.YC Biotech Co., Ltd.Not yet recruiting
-
University of NottinghamRecruitingFrailty | Diet | Systemic Inflammatory Response | Dietary Fiber | Frailty at Older Adults | Pre-FrailtyUnited Kingdom
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Maximilian KönigNot yet recruiting
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
Clinical Trials on Screening intervention
-
Ohio State University Comprehensive Cancer CenterCompletedCervical Carcinoma | Human Papillomavirus InfectionUnited States
-
Thai Red Cross AIDS Research CentreNational Institutes of Health (NIH); amfAR, The Foundation for AIDS Research; Fogarty International Center of the National Institute of HealthCompletedDepressive SymptomsThailand
-
Harvard School of Public Health (HSPH)National Cancer Institute (NCI); National Institutes of Health (NIH)CompletedColorectal Cancer | Social Determinants of HealthUnited States
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI); Makerere UniversityNot yet recruitingHIV | Tuberculosis (TB) | Pregnant HIV Positive WomenUganda
-
Toros UniversityNot yet recruitingCervical Cancer Screening | Breast Cancer Screening | Colorectal Cancer Screening | Cancer Prevention Behavior
-
National Taiwan University HospitalTerminatedPregnancy Complications | Gestational Diabetes Mellitus in PregnancyTaiwan
-
Maastricht UniversityMekelle UniversityUnknown
-
Assistance Publique - Hôpitaux de ParisCompletedAtrial Fibrillation | Sleep Apnea SyndromeFrance
-
University of WashingtonNational Cancer Institute (NCI)Completed
-
St Vincent's University Hospital, IrelandUniversity College Dublin; The Heartbeat Trust; Crofton Cardiac Centre, DublinCompletedMyocardial Infarction | Hypertension | Obesity | Diabetes | Left Ventricular DysfunctionIreland